Johnson & Johnson Launches "Dual Control" Campaign in Asia Pacific to Empower Patients with IBD to Balance Disease Management ...
SAN DIEGO -- Biomarker-informed therapy guidance improved disease control rates among patients with inflammatory bowel disease (IBD) compared with standard best care, a randomized trial showed. Among ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback